Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Tipo
Research/project funding
Posted on:
Fecha de Cierre:
Expired
Reference Number
RFA-AI-22-059
The purpose of this FOA is to establish a consortium of tuberculosis (TB) preclinical and clinical experts to systematically refine preclinical models by analyses of relevant pre-clinical and clinical data, and to provide results from optimized models to identify the most promising combination regimens for clinical testing
Categories: Health.
Categories: Health.
Estados Unidos